Clozapine-induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness.
genetics
pharmacology
psychiatry
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
20
01
2021
revised:
08
03
2021
accepted:
19
03
2021
entrez:
4
6
2021
pubmed:
5
6
2021
medline:
5
6
2021
Statut:
epublish
Résumé
Despite entailing more severe and uncommon side effects in 22q11.2DS compared to idiopathic schizophrenia, we strongly believe that clozapine should continue to be considered the gold standard for all treatment-resistant schizophrenia, even in 22qDS.
Identifiants
pubmed: 34084508
doi: 10.1002/ccr3.4134
pii: CCR34134
pmc: PMC8142464
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e04134Informations de copyright
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None declared.
Références
Br J Psychiatry. 2015 Jun;206(6):484-91
pubmed: 25745132
J Clin Psychiatry. 2012 Nov;73(11):1395-402
pubmed: 23218156
Ment Health Clin. 2018 Nov 1;8(6):313-316
pubmed: 30397574
Pediatrics. 2003 Jul;112(1 Pt 1):101-7
pubmed: 12837874
J Psychopharmacol. 2008 Sep;22(7):815-7
pubmed: 18753274
Lancet. 2002 Feb 2;359(9304):426-30
pubmed: 11844533
J Clin Psychiatry. 2019 Mar 5;80(2):
pubmed: 30840788
Psychother Psychosom. 2020;89(3):151-160
pubmed: 32045914
J Med Case Rep. 2016 Sep 29;10(1):267
pubmed: 27679991
Acta Psychiatr Scand. 2006 Jul;114(1):3-13
pubmed: 16774655
Pharmacopsychiatry. 2015 May;48(3):104-10
pubmed: 25654302
Can J Psychiatry. 2017 Nov;62(11):772-777
pubmed: 28655284
J Intellect Disabil Res. 2005 Jul;49(Pt 7):567-70
pubmed: 15966965
J Clin Psychopharmacol. 1999 Oct;19(5):435-43
pubmed: 10505585
Schizophr Res. 2018 Mar;193:126-133
pubmed: 28688742
J Med Genet. 2020 Mar;57(3):151-159
pubmed: 31506323